Screen for ALK, RET & ROS1 translocations in Non-Small Cell Lung Carcinoma (NSCLC)
LungFUSION Panel v1.0 offers a rapid screening method for detecting an oncogenic fusion partner in ALK, RET or ROS1 genes.
Can utilise a minimal 10ng cDNA template in a single well assay.
Fusion partners in any of these genes have been correlated with targeted therapies for the treatment of lung cancer
Built-in EML4 controls to determine endogenous expression of wild-type lung tissue.
FREE Sample Collection
PAN India Logistics